UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Selective resistance profiles emerging in patient-derived clinical isolates with cabotegravir, bictegravir, dolutegravir, and elvitegravir

Retrovirology, 2018-08, Vol.15 (1), p.56-56, Article 56

2018

Volltextzugriff (PDF)

Mobile phone text messaging for promoting adherence to antiretroviral therapy in patients with HIV infection

Cochrane database of systematic reviews, 2012-03 (3), p.CD009756

2012

Volltextzugriff (PDF)

Treatment intensification does not reduce residual HIV-1 viremia in patients on highly active antiretroviral therapy

Proceedings of the National Academy of Sciences - PNAS, 2009-06, Vol.106 (23), p.9403-9408

2009

Volltextzugriff (PDF)

Lower Neurocognitive Functioning in HIV-Exposed Uninfected Children Compared With That in HIV-Unexposed Children

Journal of acquired immune deficiency syndromes (1999), 2022-04, Vol.89 (4), p.441-447

2022

Volltextzugriff (PDF)

Association Between the Awareness of Antiretroviral Drugs-Related Services and Drug Accessibility During the COVID-19 Pandemic Among Patients Undergoing Antiretroviral Therapy: A Cross-Sectional Study

AIDS and behavior, 2023-03, Vol.27 (3), p.891-900

2023

Volltextzugriff (PDF)

Concentrations of Efavirenz, Tenofovir, and Emtricitabine in Obesity: A Cross-Sectional Study

Journal of acquired immune deficiency syndromes (1999), 2022-09, Vol.91 (1), p.101-108

2022

Volltextzugriff (PDF)

Efavirenz or nevirapine in three-drug combination therapy with two nucleoside or nucleotide-reverse transcriptase inhibitors for initial treatment of HIV infection in antiretroviral-naïve individuals

Cochrane database of systematic reviews, 2016-12, Vol.12 (12), p.CD004246

2016

Volltextzugriff (PDF)

Ibalizumab‐uiyk as a bridge therapy for a patient with drug‐resistant HIV‐1 infection receiving chemotherapy: A case report

Journal of clinical pharmacy and therapeutics, 2021-08, Vol.46 (4), p.1185-1187

2021

Volltextzugriff (PDF)

Microglia and p38 MAPK Inhibitors Suppress Development of Mechanical Allodynia in Both Sexes in a Mouse Model of Antiretroviral-Induced Neuropathic Pain

International journal of molecular sciences, 2023-08, Vol.24 (16), p.12805

2023

Volltextzugriff (PDF)

Individualized antiretroviral therapeutic approaches: less can be more

AIDS (London), 2017-05, Vol.31 (8), p.1065-1071

2017

Volltextzugriff (PDF)

Long‐acting injectable cabotegravir for PrEP: A game‐changer in HIV prevention?

HIV medicine, 2023-06, Vol.24 (6), p.653-663

2023

Volltextzugriff (PDF)

Changes from 2000 to 2009 in the Prevalence of HIV-1 Containing Drug Resistance-Associated Mutations from Antiretroviral Therapy-Naive, HIV-1-Infected Patients in the United States

AIDS research and human retroviruses, 2018-08, Vol.34 (8), p.672-679

2018

Volltextzugriff (PDF)

Viral reservoirs, residual viremia, and the potential of highly active antiretroviral therapy to eradicate HIV infection

Journal of allergy and clinical immunology, 2008-07, Vol.122 (1), p.22-28

2008

Volltextzugriff (PDF)

HBV, HCV, and HBV/HCV co‐infection among HIV‐positive patients in Hunan province, China: Regimen selection, hepatotoxicity, and antiretroviral therapy outcome

Journal of medical virology, 2018-03, Vol.90 (3), p.518-525

2018

Volltextzugriff (PDF)

The Impact of Certain Pharmacogenetic Differences on the Metabolism of Antiretroviral Drugs Used in A Black South African Population

Current drug metabolism, 2023-01, Vol.24 (10), p.700-708

2023

Volltextzugriff (PDF)

Improved Prediction of Salvage Antiretroviral Therapy Outcomes Using Ultrasensitive HIV-1 Drug Resistance Testing

Clinical infectious diseases, 2014-08, Vol.59 (4), p.578-588

2014

Volltextzugriff (PDF)

Abnormal laboratory findings and plasma concentration monitoring of lopinavir and ritonavir in COVID‐19

British journal of clinical pharmacology, 2021-03, Vol.87 (3), p.1547-1553

2021

Volltextzugriff (PDF)

Extracellular Vesicles in Viral Replication and Pathogenesis and Their Potential Role in Therapeutic Intervention

Viruses, 2020-08, Vol.12 (8), p.887

2020

Volltextzugriff (PDF)

Accumulation of HIV-1 drug resistance in patients on a standard thymidine analogue-based first line antiretroviral therapy after virological failure: implications for the activity of next-line regimens from a longitudinal study in Mozambique

BMC infectious diseases, 2017-09, Vol.17 (1), p.605-605, Article 605

2017

Volltextzugriff (PDF)

Epidemiology of human immunodeficiency virus (HIV) drug resistance in HIV patients with virologic failure of first‐line therapy in the country of Georgia

Journal of medical virology, 2019-02, Vol.91 (2), p.235-240

2019

Volltextzugriff (PDF)

New Perspectives on the Virologic Consequences of M184V or I in Human Immunodeficiency Virus-1 Reverse Transcriptase

The Journal of infectious diseases, 2020-09, Vol.222 (7), p.1067-1069

Kuritzkes, Daniel R

2020

Volltextzugriff (PDF)

Impact of age on CD4 recovery and viral suppression over time among adults living with HIV who initiated antiretroviral therapy in the African Cohort Study

AIDS research and therapy, 2020-11, Vol.17 (1), p.66-8, Article 66

2020

Volltextzugriff (PDF)

Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women

Cochrane database of systematic reviews, 2010-03 (3), p.CD008440

2010

Volltextzugriff (PDF)

Rate and predictors of HIV virological failure among adults on first-line antiretroviral treatment in Dar Es Salaam, Tanzania

Journal of infection in developing countries, 2021-06, Vol.15 (6), p.853-860

2021

Volltextzugriff (PDF)

Dolutegravir Inhibition of Matrix Metalloproteinases Affects Mouse Neurodevelopment

Molecular neurobiology, 2021-11, Vol.58 (11), p.5703-5721

2021

Volltextzugriff (PDF)

1 – 25 von 58.842

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(52.291)
Mit Volltextzugriff
(45.336)

Publikationsform

7 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(57.633)
Japanisch
(2.611)
Portugiesisch
(743)
Spanisch
(397)
Französisch
(292)
Deutsch
(237)
Chinesisch
(170)
Russisch
(56)
Italienisch
(55)
Türkisch
(32)
Polnisch
(28)
Niederländisch
(24)
Norwegisch
(20)
Afrikaans
(19)
Dänisch
(13)
Urdu
(11)
Tschechisch
(8)
Hebräisch
(8)
Rumänisch
(7)
Croatian
(4)

15 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(45.325)
Humans
(42.779)
Life Sciences & Biomedicine
(40.695)
Hiv
(39.216)
Human Immunodeficiency Virus
(36.562)
Hiv Infections - Drug Therapy
(30.962)
Antiretroviral Drugs
(29.876)
Female
(25.290)
Male
(24.719)
Infectious Diseases
(24.455)
Adult
(22.325)
Aids
(17.249)
Antiretroviral Therapy
(17.232)
Drug Therapy
(14.590)
Middle Aged
(14.549)
Acquired Immune Deficiency Syndrome
(14.228)
Immunology
(14.099)
Antiretroviral Therapy, Highly Active
(12.830)
Anti-Hiv Agents - Therapeutic Use
(12.120)
Antiretroviral Agents
(11.544)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(43.612)
EZB Electronic Journals Library
(33.777)
Ingenta
(28.870)
Journals@Ovid Ovid Full Text
(28.232)
IngentaConnect Journals
(23.613)
Publisher website
(12.698)
Springer Journals
(9.004)
Wiley-Blackwell Journals
(5.833)
Elsevier ScienceDirect Journals Complete
(4.489)
Oxford Journals
(4.346)
JSTOR
(4.248)
Oxford Journals 2020 Medicine
(4.144)
Wiley Online Library Full Collection 2018
(3.696)
Taylor & Francis
(3.225)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(3.065)
Nexis Uni
(3.048)
Taylor & Francis:Master (3349 titles)
(2.950)
Applied Social Sciences Index & Abstracts (ASSIA)
(2.889)
Taylor & Francis Journals Auto-Holdings Collection
(2.781)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(2.747)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Plos One
(3.870)
Journal Of Acquired Immune Deficiency Syndromes
(2.991)
Aids
(2.896)
Jaids-Journal Of Acquired Immune Deficiency Syndromes
(2.045)
Clinical Infectious Diseases
(1.776)
Clinical Infectious Diseases/clinical Infectious Diseases
(1.414)
Journal Of The International Aids Society
(1.373)
Aids Care
(1.273)
The Journal Of Infectious Diseases
(1.127)
Aids And Behavior
(1.042)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Selective resistance profiles emerging in patient-derived clinical isolates with cabotegravir, bictegravir, dolutegravir, and elvitegravir

Mobile phone text messaging for promoting adherence to antiretroviral therapy in patients with HIV infection

Treatment intensification does not reduce residual HIV-1 viremia in patients on highly active antiretroviral therapy

Lower Neurocognitive Functioning in HIV-Exposed Uninfected Children Compared With That in HIV-Unexposed Children

Association Between the Awareness of Antiretroviral Drugs-Related Services and Drug Accessibility During the COVID-19 Pandemic Among Patients Undergoing Antiretroviral Therapy: A Cross-Sectional Study

Concentrations of Efavirenz, Tenofovir, and Emtricitabine in Obesity: A Cross-Sectional Study

Efavirenz or nevirapine in three-drug combination therapy with two nucleoside or nucleotide-reverse transcriptase inhibitors for initial treatment of HIV infection in antiretroviral-naïve individuals

Ibalizumab‐uiyk as a bridge therapy for a patient with drug‐resistant HIV‐1 infection receiving chemotherapy: A case report

Microglia and p38 MAPK Inhibitors Suppress Development of Mechanical Allodynia in Both Sexes in a Mouse Model of Antiretroviral-Induced Neuropathic Pain

Individualized antiretroviral therapeutic approaches: less can be more

Long‐acting injectable cabotegravir for PrEP: A game‐changer in HIV prevention?

Changes from 2000 to 2009 in the Prevalence of HIV-1 Containing Drug Resistance-Associated Mutations from Antiretroviral Therapy-Naive, HIV-1-Infected Patients in the United States

Viral reservoirs, residual viremia, and the potential of highly active antiretroviral therapy to eradicate HIV infection

HBV, HCV, and HBV/HCV co‐infection among HIV‐positive patients in Hunan province, China: Regimen selection, hepatotoxicity, and antiretroviral therapy outcome

The Impact of Certain Pharmacogenetic Differences on the Metabolism of Antiretroviral Drugs Used in A Black South African Population

Improved Prediction of Salvage Antiretroviral Therapy Outcomes Using Ultrasensitive HIV-1 Drug Resistance Testing

Abnormal laboratory findings and plasma concentration monitoring of lopinavir and ritonavir in COVID‐19

Extracellular Vesicles in Viral Replication and Pathogenesis and Their Potential Role in Therapeutic Intervention

Accumulation of HIV-1 drug resistance in patients on a standard thymidine analogue-based first line antiretroviral therapy after virological failure: implications for the activity of next-line regimens from a longitudinal study in Mozambique

Epidemiology of human immunodeficiency virus (HIV) drug resistance in HIV patients with virologic failure of first‐line therapy in the country of Georgia

New Perspectives on the Virologic Consequences of M184V or I in Human Immunodeficiency Virus-1 Reverse Transcriptase

Impact of age on CD4 recovery and viral suppression over time among adults living with HIV who initiated antiretroviral therapy in the African Cohort Study

Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women

Rate and predictors of HIV virological failure among adults on first-line antiretroviral treatment in Dar Es Salaam, Tanzania

Dolutegravir Inhibition of Matrix Metalloproteinases Affects Mouse Neurodevelopment

Suchergebnisse filtern